Peteris Dzenis, MD
Orthopedic Surgery · Flushing, NYNPI 1982637898
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,017 of the $3,318 with a category attached, or 60.8%. Zimmer Biomet accounts for 79.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $1,749 and has fallen 90.5% since, to $166 in 2025.
Across 53 payments — averaging $62.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$3K
- Endo Pharmaceuticals Inc.$234
- Stryker$100
- Johnson & Johnson$73
- Ferring Pharmaceuticals Inc.$63
- Fidia Pharma USA Inc.$62
- plus $143 from 7 others
What the payments were for
- Travel & lodging$1,15235%
- Food & beverage$2,01761%
- Education$1494%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 22 | $2,642 |
| Endo Pharmaceuticals Inc. | 11 | $234 |
| Stryker | 3 | $100 |
| Johnson & Johnson | 3 | $73 |
| Ferring Pharmaceuticals Inc. | 3 | $63 |
| Fidia Pharma USA Inc. | 3 | $62 |
| Pacira Therapeutics, Inc. | 2 | $41 |
| Baudax Bio Inc. | 1 | $25 |
| Endo USA, Inc. | 1 | $24 |
| Anika Therapeutics, Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Baxter Healthcare | 1 | $12 |
| Gotham Surgical Solutions & Devices, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,318 in reported general payments places this provider in the 70th percentile of 91 orthopedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 50 | $19,335 |
| Diclofenac Epolamine | 22 | $15,147 |
| Diclofenac Sodium ErDiclofenac Sodium | 81 | $2,251 |
| Naproxen | 138 | $577 |
| Celecoxib | 41 | $418 |
| Meloxicam | 48 | $92 |
| Ibuprofen | 14 | $81 |
| Amoxicillin | 16 | $75 |
| Tramadol Hcl | 13 | $31 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Flushing
- Joseph ShimFlushing$202
- Baron LonnerNew York$2.1M
- Jan KoenigRockville Centre$1.4M
- Lon WeinerNew York$622K
- Andrew CappuccinoLockport$581K
- Douglas PadgettUniondale$407K
- James GladstoneNew York$260K
- Thomas WickiewiczNew York$201K
- David EssigNew York$123K
- Jason McKeanBrooklyn$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.